
Illumina launches ultrasensitive sequencing for detecting trace tumor DNA in cancer research.
Illumina has introduced an early access program for a new ultrasensitive sequencing workflow designed to detect very low levels of circulating tumor DNA (ctDNA) in plasma samples. This technology uses duplex chemistry to analyze both DNA strands, enh...

